- CEO
- David C. Robinson
- Full Time Employees
- 5
- Sector
- Industrials
- Industry
- Engineering & Construction
- Address
- United States of America
- IPO Date
- Oct 19, 2009
- Business
- TechniScan, Inc. (TSNI) develops and commercializes non-invasive medical imaging products, primarily an automated 3D ultrasound breast imaging system for the detection and diagnosis of breast cancer; the WarmHer® technology employs a fluid-filled scanning environment with thermoacoustic and ultrasound techniques to produce detailed whole-breast images without compression. Headquartered in Salt Lake City, Utah, and founded in 1984, the company targets healthcare providers and clinicians in the medical diagnostics sector, with operations focused in the United States. Its core offerings include research, development, and commercialization of ultrasound-based systems designed to complement mammography by improving early detection in dense breast tissue. Historically, TechniScan secured significant funding, including a $13 million Series E round in 2008 led by Esaote Group with an OEM and distribution agreement, $10 million equity facility, and National Cancer Institute grants totaling over $5 million, alongside a reverse merger to go public in 2010 and a 1-for-4 reverse stock split that year. No major acquisitions, partnerships, or new product launches occur within the last 1-2 years, as the development-stage firm maintains a low public profile with minimal recent disclosures amid stagnant stock activity at minimal market capitalization.